Medium materiality6/10
Lenz Therapeutics price target lowered to $7 from $12 at Piper Sandler
Why it may matterVerify against the original reporting
Buy on remaining upside potential despite downgrade.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Piper Sandler lowers LENZ target to $7; current price reported at $5.21.
- LENZ target down to 7
- LENZ price $5.21
Key facts
- 01
Target: $7
- 02
Posted price: $5.21
- 03
Analyst firm: Piper Sandler
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.